Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Libutti

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Cancer Research|January 19, 1999
In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII)P C Wu, H R Alexander, J Huang, et al.
The Journal of Biological Chemistry|October 7, 1994
Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide IIJ Kao, K Houck, Y Fan, et al.
Cancer|September 18, 1998
A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosisD L Bartlett, J F Buell, S K Libutti, et al.
Cytokine|July 6, 2000
Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II)A C Berger, H R Alexander, P C Wu, et al.
The Journal of Urology|April 1, 1995
Sutureless rabbit bladder mucosa patch graft urethroplasty using diode laser and solderA J Kirsch, D T Chang, M L Kayton, et al.
Surgery|December 17, 1998
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendationsS K Libutti, P L Choyke, D L Bartlett, et al.
The Cancer Journal From Scientific American|May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesotheliomaG Y Ma, D L Bartlett, E Reed, et al.
Annals of Surgical Oncology|October 13, 2001
A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastasesA L Feldman, H R Alexander, D L Bartlett, et al.
The American Journal of Pathology|July 17, 1998
Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysisI A Lubensky, S Pack, D Ault, et al.
Journal of the American College of Surgeons|April 9, 1999
Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasiaA C Berger, S K Libutti, D L Bartlett, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Cancer Research|January 19, 1999
In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII)P C Wu, H R Alexander, J Huang, et al.
The Journal of Biological Chemistry|October 7, 1994
Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide IIJ Kao, K Houck, Y Fan, et al.
Cancer|September 18, 1998
A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosisD L Bartlett, J F Buell, S K Libutti, et al.
Cytokine|July 6, 2000
Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II)A C Berger, H R Alexander, P C Wu, et al.
The Journal of Urology|April 1, 1995
Sutureless rabbit bladder mucosa patch graft urethroplasty using diode laser and solderA J Kirsch, D T Chang, M L Kayton, et al.
Surgery|December 17, 1998
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendationsS K Libutti, P L Choyke, D L Bartlett, et al.
The Cancer Journal From Scientific American|May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesotheliomaG Y Ma, D L Bartlett, E Reed, et al.
Annals of Surgical Oncology|October 13, 2001
A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastasesA L Feldman, H R Alexander, D L Bartlett, et al.
The American Journal of Pathology|July 17, 1998
Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysisI A Lubensky, S Pack, D Ault, et al.
Journal of the American College of Surgeons|April 9, 1999
Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasiaA C Berger, S K Libutti, D L Bartlett, et al.
Pageof 10